From Conference to the Clinic

Goals of this Program

New Information Regarding New Antidepressants: Vilazodone, Levomilnacipran, and Vortioxetine

SSRI-Associated Treatment Emergent Sexual Dysfunction After Switch to Vortioxetine or Escitalopram

SSRI-Associated TESD After Switch to Vortioxetine or Escitalopram

Post Hoc Analyses of Suicidality in Clinical Trials of Vilazodone

Suicidality in Clinical Trials of Vilazodone

Levomilnacipran ER Treatment in Adult MDD Patients With First-episode, Highly Recurrent, and Chronic MDD

Levomilnacipran ER (cont)

From Conference to the Clinic

Investigational SGAs as Adjunctive Treatment for MDD

Long-term Safety of Adjunctive Brexpiprazole (OPC-34712) in MDD: Results From 2 52-Week Open-label Studies

Long-term Safety of Adjunctive Brexpiprazole (OPC-34712) in MDD: Results From 2 52-Week Open-label Studies

Long-term Safety of Adjunctive Brexpiprazole (OPC-34712) in MDD: Results From 2 52-Week Open-label Studies (cont)

Efficacy and Safety of Cariprazine as Adjunctive Therapy in MDD A Double-blind, Randomized, Placebo-controlled Study

Efficacy and Safety of Cariprazine as Adjunctive Therapy in MDD: A Double-blind, Randomized, Placebo-controlled Study

Efficacy and Safety of Cariprazine as Adjunctive Therapy in MDD: A Double-Bblind, Randomized, Placebo-controlled Study

From Conference to the Clinic

EXPLORATION OF MECHANISMS OF ACTION AND A NEW CATEGORY OF MDD

Patterns of Antidepressant Efficacy With Quetiapine XR as Adjunct to Different Ongoing Antidepressants; Exploration of MOA Hypotheses: Study Design

Patterns of Antidepressant Efficacy With Quetiapine XR as Adjunct to Different Ongoing Antidepressants; Exploration of MOA Hypotheses: Results

Lurasidone For the Treatment of MDD With Mixed Features: A Randomized, Double-blind, Placebo-controlled 6-Week Trial: Study Design

Lurasidone For the Treatment of MDD With Mixed Features: A Randomized, Double-blind, Placebo-controlled 6-Week Trial: Results

From Conference to the Clinic

OTHER MODALITIES, OTHER TARGETS

Facing Depression Using Botulinum Toxin Update and Pooled Analysis from Clinical Trials: Study Design

Facing Depression Using Botulinum Toxin Update and Pooled Analysis from Clinical Trials: Results

A Randomized, Placebo-controlled Study of Bright Light Therapy, Fluoxetine, and the Combination, for Nonseasonal Major Depression: Study Design

A Randomized, Placebo-controlled Study of Bright Light Therapy, Fluoxetine, and the Combination, for Nonseasonal Major Depression

Effect of Vortioxetine on Cognitive Dysfunction in Subgroups of Adult MDD Patients: Study Design

Effect of Vortioxetine on Cognitive Dysfunction in Subgroups of Adult MDD Patients: Results

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)